ATE63815T1 - Verwendung von zinn-protoporphyrin und zinnmesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis. - Google Patents
Verwendung von zinn-protoporphyrin und zinnmesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis.Info
- Publication number
- ATE63815T1 ATE63815T1 AT88900434T AT88900434T ATE63815T1 AT E63815 T1 ATE63815 T1 AT E63815T1 AT 88900434 T AT88900434 T AT 88900434T AT 88900434 T AT88900434 T AT 88900434T AT E63815 T1 ATE63815 T1 AT E63815T1
- Authority
- AT
- Austria
- Prior art keywords
- tin
- psoriasis
- treatment
- medication
- manufacture
- Prior art date
Links
- LLDZJTIZVZFNCM-UHFFFAOYSA-J 3-[18-(2-carboxyethyl)-8,13-diethyl-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid;dichlorotin(2+) Chemical compound [H+].[H+].[Cl-].[Cl-].[Sn+4].[N-]1C(C=C2C(=C(C)C(=CC=3C(=C(C)C(=C4)N=3)CC)[N-]2)CCC([O-])=O)=C(CCC([O-])=O)C(C)=C1C=C1C(C)=C(CC)C4=N1 LLDZJTIZVZFNCM-UHFFFAOYSA-J 0.000 title abstract 2
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 title abstract 2
- 201000004681 Psoriasis Diseases 0.000 title abstract 2
- 229950003776 protoporphyrin Drugs 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93882286A | 1986-12-08 | 1986-12-08 | |
| US07/125,011 US4782049A (en) | 1986-12-08 | 1987-12-02 | Tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis |
| PCT/US1987/003248 WO1988004174A1 (en) | 1986-12-08 | 1987-12-07 | Use of tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis |
| EP88900434A EP0295280B1 (en) | 1986-12-08 | 1987-12-07 | Use of protoporphyrin and tin mesoporphyrin for the manufacture of a medicament for the treatment of psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE63815T1 true ATE63815T1 (de) | 1991-06-15 |
Family
ID=26823181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88900434T ATE63815T1 (de) | 1986-12-08 | 1987-12-07 | Verwendung von zinn-protoporphyrin und zinnmesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis. |
Country Status (12)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0333831B1 (en) * | 1987-09-08 | 1992-07-15 | The Rockefeller University | Use of metalloporphyrins to reverse the toxic effect of tumor therapy |
| GR1000182B (el) * | 1988-03-28 | 1992-01-20 | Univ Rockefeller | Χρησιμοποιηση πρωτοπορφυρινης κασσιτερου και μεσοπορφυρινης κασσιτερου στην παρασευη φαρμακευτικων συνθεσεων για την αγωγη της ψωριασης. |
| US4997828A (en) * | 1989-02-14 | 1991-03-05 | The Rockefeller University | Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin |
| US5192757A (en) * | 1990-12-20 | 1993-03-09 | Glaxo Inc. | Cobalt porphyrins |
| US5149697A (en) * | 1991-04-18 | 1992-09-22 | Glaxo Inc. | Cobalt porphyrin pharmaceutical compositions |
| WO1995017893A1 (en) * | 1993-12-28 | 1995-07-06 | New York Blood Center | Methods for preventing or treating hiv-1 or hiv-2 infection |
| TW247876B (en) | 1993-12-28 | 1995-05-21 | New York Blood Ct Inc | Pharmaceutical compositions for prevention or treating HIV-1 or HIV-2 infection |
| EP0765161A2 (en) * | 1994-06-02 | 1997-04-02 | Bar-Ilan University | Synergistic antibiotic compositions containing a perphyrin and an antibiotic |
| FR2727862B1 (fr) * | 1994-12-07 | 1997-03-28 | Holzmann Stephane | Produits cosmetiques et/ou d'hygiene corporelle et/ou dermatologiques constitues d'une phase aqueuse isotonique et/ou d'une phase aqueuse osmotique |
| US5929064A (en) * | 1995-08-02 | 1999-07-27 | Warner-Lambert Company | Amino acid complexes of cobalt (III) mesoporphyrin IX and cobalt (III) protoporphyrin IX |
| US7375216B2 (en) * | 2002-06-04 | 2008-05-20 | Infacare Pharmaceutical Corporation | Preparation of metal mesoporphyrin compounds |
| AU2003237349B2 (en) | 2002-06-04 | 2010-06-03 | Infacare Pharmaceutical Corporation | Preparation of metal mesoporphyrin halide compounds |
| US20040097481A1 (en) * | 2002-11-20 | 2004-05-20 | Benjamin Levinson | Water-soluble mesoporphyrin compounds and methods of preparation |
| US20060222668A1 (en) * | 2005-04-01 | 2006-10-05 | Wellspring Pharmaceutical Corporation | Stannsoporfin compositions, drug products and methods of manufacture |
| PT2079472E (pt) * | 2006-10-04 | 2011-11-24 | Infacare Pharmaceutical Corp | Preparação em larga escala de estansoporfina de alta pureza |
| ES2609110T3 (es) | 2011-03-30 | 2017-04-18 | Infacare Pharmaceutical Corporation | Procedimientos de síntesis de mesoporfirinas metálicas |
| AU2015324103C1 (en) | 2014-09-29 | 2020-08-20 | Fred Hutchinson Cancer Center | Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers |
| CA3225692A1 (en) * | 2021-07-12 | 2023-01-19 | Donald Jeffrey Keyser | Metal protoporphyrin for treatment of bk virus |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4454152A (en) * | 1980-05-07 | 1984-06-12 | Hoffmann-La Roche Inc. | Methoxsalen dosage forms |
| US4657902A (en) * | 1985-03-25 | 1987-04-14 | The Rockefeller University | Therapeutic use of tin mesoporphyrin |
| US4692439A (en) * | 1986-06-20 | 1987-09-08 | The Rockefeller University | Therapeutic use of tin diiododeuteroporphyrin |
-
1987
- 1987-12-02 US US07/125,011 patent/US4782049A/en not_active Expired - Lifetime
- 1987-12-07 AT AT88900434T patent/ATE63815T1/de not_active IP Right Cessation
- 1987-12-07 DE DE8888900434T patent/DE3770465D1/de not_active Expired - Lifetime
- 1987-12-07 EP EP88900434A patent/EP0295280B1/en not_active Expired - Lifetime
- 1987-12-07 KR KR1019880700932A patent/KR920002330B1/ko not_active Expired
- 1987-12-07 JP JP63500719A patent/JPH01501627A/ja active Granted
- 1987-12-07 AU AU10812/88A patent/AU597144B2/en not_active Ceased
- 1987-12-07 CA CA000553714A patent/CA1302253C/en not_active Expired - Lifetime
- 1987-12-07 WO PCT/US1987/003248 patent/WO1988004174A1/en active IP Right Grant
- 1987-12-08 IE IE332387A patent/IE63507B1/en not_active IP Right Cessation
- 1987-12-08 PH PH36181A patent/PH25224A/en unknown
-
1988
- 1988-08-08 DK DK443088A patent/DK443088A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK443088D0 (da) | 1988-08-08 |
| EP0295280A1 (en) | 1988-12-21 |
| AU1081288A (en) | 1988-06-30 |
| IE873323L (en) | 1988-06-08 |
| IE63507B1 (en) | 1995-05-03 |
| EP0295280A4 (en) | 1989-02-21 |
| US4782049A (en) | 1988-11-01 |
| JPH0585523B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-12-07 |
| EP0295280B1 (en) | 1991-05-29 |
| DE3770465D1 (de) | 1991-07-04 |
| KR890700026A (ko) | 1989-03-02 |
| WO1988004174A1 (en) | 1988-06-16 |
| JPH01501627A (ja) | 1989-06-08 |
| CA1302253C (en) | 1992-06-02 |
| DK443088A (da) | 1988-08-08 |
| AU597144B2 (en) | 1990-05-24 |
| PH25224A (en) | 1991-03-27 |
| KR920002330B1 (ko) | 1992-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE63815T1 (de) | Verwendung von zinn-protoporphyrin und zinnmesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis. | |
| ATE127342T1 (de) | Verwendung von modafinil zur herstellung eines antiischämischen arzneimittels. | |
| DE3770190D1 (de) | Beleuchtungsanordnung fuer ein system zur behandlung eines patienten durch photoaktivierung. | |
| DE69421778D1 (de) | Verwendung von wirksamen Mengen von aktiven Stoffen zur Behandlung von Mischhaut | |
| ATE82133T1 (de) | Verwendung von einem cartilago-induzierenden faktor (cif) zur herstellung eines arzneimittels zur behandlung von entzuendungen. | |
| DE3881299D1 (de) | Retinoide zur behandlung lichtgeschaedigter haut. | |
| ATE184193T1 (de) | Verwendung von n-acylaminoalkoholen zur herstellung eines arzneimittels zur behandlung von mastzellerkrankungen | |
| ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
| ATE116848T1 (de) | Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris. | |
| ATE99932T1 (de) | Verwendung von pyrrolicloncarbonsaeurealkylestern zur herstellung eines arzneimittels zur behandlung von ichtyosis. | |
| ATE191849T1 (de) | Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst | |
| ATE220923T1 (de) | Rekombinante adenoviren und deren verwendung in der gentherapie zur behandlung von augenerkrankungen | |
| ATE83378T1 (de) | Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen. | |
| ATE107168T1 (de) | Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression. | |
| ATE79254T1 (de) | Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen. | |
| ATE78395T1 (de) | Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht. | |
| DE69026511D1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
| ATE42462T1 (de) | Licht- und sonnenschutzmittel. | |
| DE68905657D1 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
| ATE69949T1 (de) | Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| DE69600367D1 (de) | Verwendung von Sulfasalazin und/oder dessen aktiven Metaboliten zur Herstellung eines Arzneimittels zur Behandlung von venöser Insuffizienz und venösen Ulcera | |
| DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
| ATE86105T1 (de) | Verwendung von probucol zur herstellung eines arzneimittels fuer die behandlung von herzarrhythmie. | |
| ATE108331T1 (de) | Verwendung von tnf zur herstellung eines arzneimittels zur behandlung von psoriasis. | |
| ATE122886T1 (de) | Verwendung von 1,4-dihydropyridin-derivaten in der behandlung von alkoholsucht. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |